OpenAI buys biotech startup Orchestra Bio to expand commercial life science tools
OpenAI has purchased life sciences software creator Orchestra Bio to bolster its enterprise tools for pharmaceutical clients. Orchestra specializes in building automated assistants that manage clinical trials and manufacturing rather than discovering original drugs.
